三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
已上市PARP抑制剂治疗前列腺癌的疗效及安全性对比
已上市PARP抑制剂治疗前列腺癌的疗效及安全性对比
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:127KB
图片尺寸:2298*499
同报告图片
/
4
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
所属报告:
恒瑞医药(600276)-A股公司研究报告:创新药收获期已至国际化战略加速-250927(94页).pdf
打包全文图表
相关数据
JAK抑制剂在骨髓纤维化治疗中的竞争格局
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
收藏
竞争格局
2026-06-26
原图定位
查看详情
ZG006临床2期研究的安全性数据(10mg剂量)
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
收藏
行业数据
2026-06-26
原图定位
查看详情
ZG006临床2期研究的安全性数据(30mg剂量)
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
收藏
行业数据
2026-06-26
原图定位
查看详情
2020-2034E中国非临床安全性评价市场规模(亿美元)
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
收藏
市场规模
2026-05-25
原图定位
查看详情
《KAT6抑制剂化合物、药物组合物及其制备方法和N-(6-((1H-pyrazol-1-yl)methyl)-4-metho
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
收藏
行业数据
2026-05-11
原图定位
查看详情
图10、全球PD-(L)1抑制剂市场规模(十亿美元)
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
收藏
市场规模
2026-05-11
原图定位
查看详情
临床数据显示国产厂商有效性安全性比肩达芬奇
收藏
行业数据
2026-04-27
原图定位
查看详情
图10.VMAT2抑制剂全球销售情况(亿美元)
收藏
行业数据
2026-04-20
原图定位
查看详情
全球PCSK9抑制剂市场规模(亿美元)
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
收藏
市场规模
2026-04-13
原图定位
查看详情
中国PCSK9抑制剂市场规模(亿人民币)
收藏
市场规模
2026-04-13
原图定位
查看详情
食品安全监管模式全链条、全周期、全要素系统性治理升级
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
收藏
商业模式
2026-04-03
原图定位
查看详情
相较于PD-(L)1抑制剂,PD-(L)1/VEGF双抗有极大替代和拓展空间
收藏
行业数据
2026-03-31
原图定位
查看详情
表2-7中国预制菜供应链安全性评估
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
收藏
自研数据
2026-03-04
原图定位
查看详情
图 4:煤炭龙头把安全议题列为实质性议题之首(中国神化、兖矿能源、中煤能源等)
fCDorq7popjnvJblj7cgfCDlr7nkuK3nhaTog73mupDlj5HlsZXnmoTph43opoHmgKcgfCDlr7nliKnnm4rnm7jlhbPmlrnnmoTph43opoHmgKcgfAp8LS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCAxICAgICAgICB8IOmrmCAgICAgICAgICAgICAgICAgICAgIHwg6auYICAgICAgICAgICAgICAgICAgIHwKfCAyICAgICAgICB8IOS4rSAgICAgICAgICAgICAgICAgICAgIHwg6auYICAgICAgICAgICAgICAgICAgIHwKfCAzICAgICAgICB8IOS4rSAgICAgICAgICAgICAgICAgICAgIHwg5LitICAgICAgICAgICAgICAgICAgIHwKfCA0ICAgICAgICB8IOS9jiAgICAgICAgICAgICAgICAgICAgIHwg5LitICAgICAgICAgICAgICAgICAgIHwKfCA1ICAgICAgICB8IOS4rSAgICAgICAgICAgICAgICAgICAgIHwg5LitICAgICAgICAgICAgICAgICAgIHwKfCA2ICAgICAgICB8IOS4rSAgICAgICAgICAgICAgICAgICAgIHwg5LitICAgICAgICAgICAgICAgICAgIHwKfCA3ICAgICAgICB8IOS9jiAgICAgICAgICAgICAgICAgICAgIHwg5L2OICAgICAgICAgICAgICAgICAgIHwKfCA4ICAgICAgICB8IOS9jiAgICAgICAgICAgICAgICAgICAgIHwg5L2OICAgICAgICAgICAgICAgICAgIHwKfCA5ICAgICAgICB8IOS9jiAgICAgICAgICAgICAgICAgICAgIHwg5L2OICAgICAgICAgICAgICAgICAgIHwKfCAxMCAgICAgICB8IOS4rSAgICAgICAgICAgICAgICAgICAgIHwg5LitICAgICAgICAgICAgICAgICAgIHwKfCAxMSAgICAgICB8IOS4rSAgICAgICAgICAgICAgICAgICAgIHwg5L2OICAgICAgICAgICAgICAgICAgIHwKfCAxMiAgICAgICB8IOS4rSAgICAgICAgICAgICAgICAgICAgIHwg5L2OICAgICAgICAgICAgICAgICAgIHwKfCAxMyAgICAgICB8IOS9jiAgICAgICAgICAgICAgICAgICAgIHwg5L2OICAgICAgICAgICAgICAgICAgIHwKfCAxNCAgICAgICB8IOS4rSAgICAgICAgICAgICAgICAgICAgIHwg5LitICAgICAgICAgICAgICAgICAgIHwKfCAxNSAgICAgICB8IOS4rSAgICAgICAgICAgICAgICAgICAgIHwg6auYICAgICAgICAgICAgICAgICAgIHwKfCAxNiAgICAgICB8IOS9jiAgICAgICAgICAgICAgICAgICAgIHwg5L2OICAgICAgICAgICAgICAgICAgIHwKfCAxNyAgICAgICB8IOS4rSAgICAgICAgICAgICAgICAgICAgIHwg5LitICAgICAgICAgICAgICAgICAgIHwKfCAxOCAgICAgICB8IOS9jiAgICAgICAgICAgICAgICAgICAgIHwg5L2OICAgICAgICAgICAgICAgICAgIHwKfCAxOSAgICAgICB8IOS9jiAgICAgICAgICAgICAgICAgICAgIHwg5LitICAgICAgICAgICAgICAgICAgIHwKfCAyMCAgICAgICB8IOS9jiAgICAgICAgICAgICAgICAgICAgIHwg5LitICAgICAgICAgICAgICAgICAgIHwKfCAyMSAgICAgICB8IOS9jiAgICAgICAgICAgICAgICAgICAgIHwg5L2OICAgICAgICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8mueFpOeCrem+meWktOaKiuWuieWFqOiurumimOWIl+S4uuWunui0qOaAp+iurumimOS5i+mmlu+8iOS4reWbveelnuWMluOAgeWFluefv+iDvea6kOOAgeS4reeFpOiDvea6kOetie+8iQ==
收藏
行业数据
2026-03-03
原图定位
查看详情
表2-7中国精酿啤酒供应链安全性评估
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
收藏
自研数据
2026-03-02
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
PARP 抑制剂,BRCA突变前列腺癌的刚性用药。前列腺癌患者群体庞大(20 年全球新发患者 141 万人),且晚期患者最终转归至 mCRPC,新型内分泌治疗耐药后面临无药可用的境地。PARP 抑制剂的出现为伴 BRCA 突变的前列腺癌患者提供了新的治疗手段(相较内分泌治疗,2L 治疗 rPFS 提升 3.8 个月,OS 提升 4.4 个月,ORR 为 33%,PROfound 研究),同时也打开了新的市场(前列腺癌突变率约 10%)。当前奥拉帕利 2L mCRPC 适应症已经获批,更多药物组合也在向 1L mCRPC 与 HSPC 阶段探索,有望为前列腺癌患者带来更多获益。
行业数据
原图定位
当前图表所属:
恒瑞医药(600276)-A股公司研究报告:创新药收获期已至国际化战略加速-250927(94页).pdf
恒瑞医药:各业务板块收入占比
SHR4640主要临床进展
URAT1:苯溴马隆国内样本医院销售额
URAT1:全球销售额
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》